Endovia Health Sciences (EDVA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 11 34 sessions, August 24, 2026 to October 9, 2026
- Largest daily move
- -12.7% close of August 26, 2026
- 1-month change
- -36.1% closing prices, September 9, 2026 to October 9, 2026
Company Description
Endovia Health Sciences (NYSE: EDVA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.1M.
EDVA has declined 36.1% over the past month. The last closing price was $0.1560.
For FY2025, Endovia Health Sciences reported revenue of $73K and diluted earnings per share of -$11.97.
This page collects what Stock Titan holds for EDVA, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Endovia Health Sciences (EDVA) closed at $0.1560 on October 9, 2026. Over the past month, the price has lost 36.1%.
EDVA Metrics & Rankings
Price returns through October 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Endovia Health Sciences has 4 recent news articles, with the latest published 5 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial. View all EDVA news →
SEC Filings
Endovia Health Sciences has filed 10 recent SEC filings, including 6 Form 8-K, 2 Form PRE 14A, 1 Form DEF 14A, 1 Form 424B3. The most recent filing was submitted on October 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EDVA SEC filings →
Financial Highlights
Endovia Health Sciences generated $73K in revenue in FY2025, retaining a 23.1% gross margin. Diluted earnings per share stood at -$11.97. The company generated -$4.8M in operating cash flow. The current ratio was 0.04, measuring current assets divided by current liabilities.
Upcoming Events
FDA meeting
Potential veterinary launch
Endovia Health Sciences has 2 upcoming scheduled events. The next event, "FDA meeting", is scheduled for November 19, 2026 (in 39 days). Investors can track these dates to stay informed about potential catalysts that may affect the EDVA stock price.
Short Interest History
Short interest in Endovia Health Sciences (EDVA) currently stands at 339.3 thousand shares, up 48.6% from the previous reporting period, representing 5.3% of the shares outstanding. Since August 2026, short interest has increased by 48.6%.
Days to Cover History
Days to cover for Endovia Health Sciences (EDVA) currently stands at 1.5 days, up 54% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 54%.
EDVA Company Profile & Sector Positioning
Endovia Health Sciences (EDVA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.